NYSE: ASPNAspen Aerogels Inc Stock
$3.69-0.09 (-2.38%)
Updated Apr 7, 2026
ASPN Price
$3.69
Fair Value Price
N/A
Market Cap
$305.63M
52 Week Low
$2.30
52 Week High
$9.76
P/E
-0.78x
P/B
1.3x
P/S
0.86x
PEG
N/A
Dividend Yield
N/A
Revenue
$271.10M
Earnings
-$389.55M
Gross Margin
17%
Operating Margin
-138.86%
Profit Margin
-143.7%
Debt to Equity
0.73
Operating Cash Flow
$33M
Beta
2.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ASPN Overview
Aspen Aerogels, Inc. manufactures aerogel insulation products used in the energy infrastructure and building materials markets in the U.S. and internationally. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries, and Pyrogel XTE which reduces the risk of corrosion under insulation in energy infrastructure operating systems. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market. Cryogel X201 is used in cold systems. Aspen was founded in 2001 and is headquartered in Northborough, MA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ASPN's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Product & Equipment
Industry Rating
D
ASPN
Ranked#25 of 27
Ranked#25 of 27
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $30.21 | A | |
| $14.15 | A | |
| $24.82 | B |
Be the first to know about important ASPN news, forecast changes, insider trades & much more!
ASPN News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ASPN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ASPN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASPN is good value based on its book value relative to its share price (1.3x), compared to the US Building Products & Equipment industry average (5.43x)
P/B vs Industry Valuation
ASPN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ASPN due diligence checks available for Premium users.
Valuation
ASPN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.78x
Industry
26.86x
Market
29.87x
ASPN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.3x
Industry
5.43x
ASPN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ASPN's financial health
Profit margin
Revenue
$41.3M
Net Income
-$72.9M
Profit Margin
-176.4%
ASPN's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ASPN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$406.7M
Liabilities
$171.2M
Debt to equity
0.73
ASPN's short-term assets ($242.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASPN's short-term assets ($242.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASPN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ASPN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$16.1M
Investing
-$2.5M
Financing
-$7.5M
ASPN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ASPN vs Building Product & Equipment Stocks
Aspen Aerogels Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.